2023 Outlook and Macro – as we continue through August, executives have provided thoughts on anticipated trends for the remainder of 2023
Heading into Q2 earnings, our Q2’23 Inside The Buy-Side® Earnings Primer® found investor views converging with those of management. Bearish investor sentiment receded while management tone was perceived as increasingly cautionary, resulting in a more neutral outlook, collectively. Capital deployment preferences overwhelmingly favored debt paydown for companies with net debt-to-EBITDA levels above 2.0x, though reinvestment continued to garner increasing support QoQ.
With Q2 2023 earnings season in the books, we “Close the Quarter” with some notable themes:
Despite 79% of the S&P 500 reporting positive EPS surprises, above both the 1-year (73%) and 5-year averages (77%), stock price reactions for those surpassing analyst estimates have been negative1, on average. Although the average surprise factor for Q2 clocked in at +7.8% above consensus, below the 5-year average (+8.4%) but above the 10-year average +(6.4%), positive surprises were met with an average share price depreciation of -0.5%. Interestingly, if -0.5% is the final percentage for the quarter, it will mark the largest average negative price reaction to positive EPS surprises reported by S&P 500 companies for a quarter since Q2 2011 (-2.1%)2.
Put another way, implied expectations were much higher in July than they were in January, yet the Street’s growth estimates in aggregate remained muted post-Q2 earnings.
When splitting the S&P 500 universe into:
As shown below, aggregate YoY revenue declined 6.5% for companies with greater than 50% of their revenues coming from abroad compared to a 3.2% increase for those with larger U.S. revenue sources.
Additionally, aggregate EPS growth declined 5.0% for those in the international camp versus a 1.9% uptick for companies in the U.S camp. Of note, the WSJ Dollar Index5 ended largely flat for the calendar Q2 period, increasing just 0.8% and currently registers down 1.0% YTD.
When digging a layer deeper, the data suggests that greater China exposure in particular more negatively impacted Q2 growth rates. When parsing the S&P 500 into those with at least 5% of revenues coming from China and, further, those with at least 20% exposure, stark disparities begin to emerge.
In fact, investor sentiment reflects this reality. Heading into Q2 earnings, our Inside The Buy-Side® Earnings Primer® identified souring China sentiment, with 79% of participants exhibiting more concern or a continued high level of concern over U.S.-China relations. Moreover, the perceived risk profile for companies with operational exposure to the country increased to 82% after hovering ~70% over the past year, with sentiment toward the Chinese economy recording its largest level of bearishness since March 2022, according to our Earnings Primer® (the height of the Chinese Communist Party’s Zero-COVID policy measures).
During the entirety of Q2 2023, the average stock price reaction6 to earnings reports for companies with >20% of revenues coming from China was relatively similar compared to the broader S&P 500 average (-0.9% versus -0.4%, respectively). However, share performances since the beginning of August are increasingly reflecting more concern around China exposure, as this differential cited above has widened during August to 6%.
Contributing factors include: the People’s Bank of China unexpectedly cutting rates on Tuesday in an effort to spur consumer activity, a flurry of weaker-than-expected economic indicators published last week (namely, Chinese retail sales, investment, and industrial output), the suspension of their youth jobless data, which hit a record high of 21.3% in June, and continued tensions in U.S.-China relations, with new tariffs introduced as recently as Thursday.
Time will tell how these China-heavy companies perform in the back half of 2023. For now, investor sentiment, executive commentary, and policymaking in Washington appear to point to less-than-ideal fundamentals and deteriorating sentiment for companies with exposure to China.
As we do every quarter, we analyzed annual revenue and EPS guidance provided by U.S. companies with market caps greater than $500M that have reported to-date.9 Below are our findings:10
Breakdown by Sector
81% of full-year 2023 revenue growth guidance midpoints are above 2022 actuals, down slightly from 83% last quarter.
80% of companies who raised annual revenue guidance increased both the bottom and top of their ranges, while 79% of those who lowered decreased both the top and bottom of their ranges.
Companies that maintained annual revenue guidance (n = 241) have an average spread of 4.2%.
61% of full-year 2023 EPS growth guide midpoints are above 2022 actuals, just below 62% last quarter.
81% of companies who raised annual EPS guidance increased both the bottom and top of their ranges, while 84% of those who lowered decreased both the top and bottom of their ranges.
Companies that maintained annual EPS guidance (n = 184) have an average spread of $0.28.
Approximately 38% of analysts increased 2023 top-line estimates, while half increased EPS expectations for the same period. Leading the revenue increases were defensive sectors, including Consumer Staples and Healthcare, while Energy and Materials experienced the largest top- and bottom-line cuts amid changes in commodity price assumptions.
Indeed, roughly 30% of all sectors experienced negative annual consensus revisions for both revenue and EPS.
To garner insights into capital spending trends, we analyzed the average sector cash allocations within the S&P 500:
Digging a bit deeper, inside our Inside The Buy-Side® Earnings Primer® also identified buybacks as the lowest preferred use of cash by investors, with only 12% placing it as one of their top-two preferred uses of cash, and 46% recommending companies moderate or cease buyback activity. This aligns with the data above coming out of the S&P 500, as the majority of sectors experienced material decreases in share repurchases, most notably in the Energy, Communications, and Healthcare sectors.
In terms of deal activity more broadly, M&A decreased in July by 17% MoM, as incremental deal values decreased by 26%, according to FactSet. These figures represent a 33% YoY decline in deal volume but with a 20% increase YoY in aggregate M&A spending. Again, these data suggest a wait-and-see attitude by corporates that we saw in our most recent Inside The Buy-Side® Earnings Primer®.
As we continue through August, executives have provided thoughts on anticipated trends for the remainder of 2023. We have bucketed these forward-looking themes below:
Despite the gains seen in equity markets through July and increased hope for averting a hard economic landing, there is still a lot of uncertainty out there for both our clients and investors (we’re seeing some of that nervousness manifest itself in August’s market performance). We heard this loud and clear (and early) in our latest Inside The Buy-Side® Earnings Primer®.
With the historically volatile months of September and October in front of us, companies will be challenged to be mindful of more potential changes in the macro data while continuing to offer a reassuring narrative to investors. That said, as we often advise our clients, it’s better not to own the macro — focus on communicating what is under your control, and remain transparent about your long-term strategy, operations, and outlook.